We found significant differences in CX3CL1 concentration in both fibrotic groups, IPF and OFI (other fibrosis than IPF) groups, compared to the non-fibrotic (NFI) group of patients (p < 0.001). The gene discussed is CX3CL1; the disease is idiopathic pulmonary fibrosis.